Valetudo Therapeutics LLC
SEC insider (Form 3/4/5 filer). CIK 0002067359. 10% Owner at Liminatus Pharma, Inc. (LIMN). 2 reported Form 4/5 transactions since Sep 2024; latest on Jul 2, 2026. Located in FULLERTON, CA.
Companies Valetudo Therapeutics LLC has filed insider reports for
- Liminatus Pharma, Inc. (LIMN): 10% Owner
Valetudo Therapeutics LLC
CIK: 0002067359
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LIMN
Liminatus Pharma, Inc.
10% Owner